Dimethylaminomicheliolide Sensitizes Cancer Cells to Radiotherapy for Synergistic Combination with Immune Checkpoint Blockade.

Li, Yingying; Ni, Kaiyuan; Chan, Christina; Guo, Nining; Luo, Taokun; Han, Wenbo; Culbert, August; Weichselbaum, Ralph R; Lin, Wenbin

Li, Yingying; Ni, Kaiyuan; Chan, Christina; Guo, Nining; Luo, Taokun; Han, Wenbo; Culbert, August; Weichselbaum, Ralph R; Lin, Wenbin.

Afiliación

Li Y; Department of Chemistry University of Chicago Chicago, IL 60637, USA.
Ni K; Department of Chemistry University of Chicago Chicago, IL 60637, USA.
Chan C; Department of Chemistry University of Chicago Chicago, IL 60637, USA.
Guo N; Department of Chemistry University of Chicago Chicago, IL 60637, USA.
Luo T; Department of Chemistry University of Chicago Chicago, IL 60637, USA.
Han W; Department of Chemistry University of Chicago Chicago, IL 60637, USA.
Culbert A; Department of Chemistry University of Chicago Chicago, IL 60637, USA.
Weichselbaum RR; Department of Radiation and Cellular Oncology and The Ludwig Center for Metastasis Research University of Chicago, Chicago, IL 60637, USA.
Lin W; Department of Chemistry University of Chicago Chicago, IL 60637, USA.

Adv Ther (Weinh) ; 5(1)2022 Jan.

Article en En | MEDLINE | ID: mdl-35812344

Palabras clave

cancer; immune checkpoint blockade; immunotherapy; radiosensitizer; radiotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Adv Ther (Weinh) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google